Maanta waxaa loo isticmaali karaa, shucaac baaxad leh waa nooc ka mid ah daaweynta shucaaca loo isticmaalo Hodgkin's lymphoma kaas oo gacan ka geystey kor u kaca heerarka daaweynta ee 1960-maadkii.
Radiation waxaa la geeyaa meel ballaaran oo qoorta ah, laabta, iyo kilkisha si loo daboolo dhammaan meeraha qanjirada ugu weyn ee qeybta sare ee jirka. Qayb ka mid ah sanbabada, wadnaha iyo garbaha ayaa laga ilaaliyay maqaarka shucaaca si loo yareeyo saameynta daawada.
Ereyga 'mantle' waxaa laga soo qaatay magaca dharka, sida qafiska, wuxuu isticmaalaa sanado badan. Nooca aagga la soo bandhigay - shucaaca-wuxuu leeyahay wareegyo isku mid ah dhar xidhashada.
Noocyada noocan ah ee shucaac ballaadhan badanaaba lama isticmaalo maanta. Si kastaba ha noqotee, dhowr sano ka dib, marka daaweynta kiimikada ee aad u firfircoon ee daaweynta lymfoma ee Hodgkin aan la helin, farsamadan waxaa loo isticmaalay in lagu guuleysto tiro badan oo bukaan ah oo qaba cudurka Hodgkin ee hore. Horumarka daaweynta, daaweynta kemotherabi waxaa hadda loo isticmaalaa dhammaan bukaanada iyo shucaaca waxaa la geeyaa meel yar oo horayba u ballaarisay noodbeeska - farsamo ayaa loogu yeeraa shucaac field.
Ma aha in lagu wareero: Lymphoma Mantle
Shucaacaha mantarka leh ma laha wax la sameeyo laf-dhabarka unugyada laf-dhabarka , nooca non-Hodgkin lymphoma.
Taariikhda
Hummgkin lymphoma waxay ahayd sidii ay u dhinteen kansarka sanbabada maanta, sida lagu xusay Hodgson bishii December 2011 ee daabacaadda "Hematology, Barnaamijka Waxbarashada ASHH." Farsameed loo yaqaan daaweynta shucaaca dabaysha ee cudurka Hodgkin ee hore, hase yeeshee dadka ka badbaaday waxa ay saameyn xun ku yeesheen sanadaha shucaac, ama waxay ku daahiraan sunta, oo ay ku jiraan cudurada wadnaha iyo kansarrada labaad.
Marka tan la ogaado, shaqada ayaa bilaabay inay hagaajiso xakamaynta cudurrada iyadoo yareyneysa sunta. Hagaajinta daaweynta shucaaca iyo isticmaalka ay la socoto kiimiko casri ah ayaa la filayaa in ay keento dhimis weyn oo ku dhaca dhacdooyinka dambe.
Kansarka Naas ka dib Mantle RT
Khatarta kansarka naasaha kadib daaweynta shucaaca dabka (RT) ee loogu talagalay Hodgkin lymphoma ayaa ah mid walaac leh.
Mantle RT waa in lafaha ciridka ee kilkisha, laabta, iyo qoorta-lugaha ama axillary, dhexdhexaadinta, iyo nuucyada afka ilmagaleenka - ay la xiriiraan 2 ilaa 20-laab halista khatarta ah ee kansarka naaska, iyadoo ku xiran da'da daaweynta. Daraasadaha intooda badani waxay ogaadeen in khatarta ay ku badan tahay dumarka la daweeyey ka hor da'da 20 sano. Kansarka naasuhu wuxuu ku dhowaad 40 boqolkiiba kansarka labaad ee dumarka ka badbaaday.
Cudurka Wadnaha iyo Mantarka RT
Shucaac waxaa dhici karta in uu wadnuhu waxyeelo u geysto siyaabo kala duwan. Daraasadaha qaarkood ee xayawaanka ayaa muujiyay in shucaacu uu kicin karo jawaab-celin barar ah oo keena dabo-baxa xididada wadnaha oo sii xumaanaya ama khatar badan leh marka la kobciyo. Saameyn kale oo ka dambeeya shucaac ayaa laga yaabaa inay sii dheeraato lakabka gudaha ee qaar ka mid ah xididdada dhiigga ee caadi ahaan bixiya muruqa wadnaha.
Hore u soco
Kooxaha falanqaynta ayaa muujinaya muhiimada ay leedahay baaritaanka noocyada bukaanka halista ah ee loogu talagalay sunta soo baxa ee ka soo baxa daaweynta Hodgkin lymphoma ee sanadaha soo dhaafay.
Isbeddelada weyn ee daaweynta kiimikada iyo daaweynta shucaaca ee loo isticmaalo daaweynta Hodgkin lymphoma 10-20kii la soo dhaafay ayaa la filayaa in ay keenaan noocyo kala duwan oo waxyeellada ka duwan marka loo eego waxa laga yaabo inay ku salaysan yihiin daraasaddaha imika ee saameynta dambe.
Ilaha:
Society Cancer Society. Daweynta shucaaca ee cudurka Hodgkin.
Schaapveld M, Aleman BM, van Eggermond AM, iyo al. Kansarka labaad wuxuu halis u yahay ilaa 40 sano ka dib daawaynta Hodgkin's lymphoma. N Engl J Med . 2015; 373 (26): 2499-511.
Hodgson DC. Saamaynta dambe ee xilliga daaweynta casriga ah ee loo yaqaan 'Hodgkin Lymphoma'. Barnaamijka Waxbarashada Xanuunka Caafimaadka ee Hematol. 2011; 2011: 323-9.